Characteristic | N = 123 | % |
---|---|---|
Median age, yr (IQR) | 54 (48 to 66) | |
Tumor stage | 32 | 26.0 |
T1 | 79 | 64.2 |
T2 | 7 | 5.7 |
T3 | 4 | 3.3 |
T4 | 1 | 0.8 |
Node-positive disease | 57 | 47.3 |
Metastatic disease | 6 | 4.9 |
TNM stage | ||
I | 19 | 15.4 |
II | 70 | 56.9 |
III | 28 | 22.8 |
IV | 6 | 4.9 |
HER2-positiveb | 53 | 43.1 |
CIP2A expression | ||
Negative | 4 | 3.3 |
Low | 44 | 35.8 |
Moderate | 55 | 44.7 |
High | 20 | 16.3 |
Positive p-Akt expression | 120 | 97.6 |